Objective: Some children with type 1 diabetes (T1D) develop a transient recovery phase of beta cell function after diagnosis, also called partial remission (PR). Our aim is to describe the body mass index (BMI), dietary intake/quality, and glycemic metrics of children with clinical PR of T1D one year after diagnosis and explore associations with pubertal stage.

Methods: Children aged 1-17 yo with T1D diagnosis ≥1 year, at least 1 positive T1D antibody, receiving care at the Penn State Pediatric Diabetes Clinic and with PR (defined by an insulin dose-adjusted HbA1C index [IDAA1C] ≤9 were included. Dietary intake was assessed by a single 24-hour recall (ASA24®). Diet quality was assessed by the Healthy Eating Index (HEI-2015). Data were reported as median ± interquartile ranges (IQR), frequencies and percentages. Comparisons by pubertal stage were performed using the Fisher’s exact and Wilcoxon rank-sum tests (p=0.05).

Results: We identified 21 remitters: 62% M, 10.9 ± 3.96 yo, 71% White, 57% pump users, and 90% private insurance. T1D duration= 29 ± 18 months, HbA1C= 6.06 ± 0.53%, blood glucose= 137.9 ± 19.56 mg/dL, IDAA1C= 8.06 ± 0.94, and 95% were on CGMs. BMI at diagnosis vs. enrollment= 18.63 ± 4.54 kg/m2 and 16.6 ± 2.92 kg/m2; and 62% were prepubertal at diagnosis. Most participants had healthier BMI at diagnosis vs. enrollment: 73.7% vs. 57.1% (p<0.05). Dietary intake = 1792 ± 347.2 kcal; carbohydrates (CHO) = 40.1 ± 8.2%, fats 41.9 ± 8.05%, protein 17.7 ± 5.8%, CHO intake = 188.4 ± 59.5 g/day. HEI-2015 = 58 ± 12.6. Pre-pubertal participants had higher rates of overweight/obesity at enrollment than at diagnosis (p=0.0135).

Conclusion: Most remitters had lower BMI percentiles at diagnosis, but those who were pre-pubertal increased their BMI significantly during the course of the disease.

Disclosure

L. Huerta-Saenz: None. M. Vliem: None. J.A. Benavides-Vasquez: None. E. Deng: None. C. Lugone: Speaker's Bureau; Dexcom, Inc. Employee; Dexcom, Inc. Speaker's Bureau; Sanofi. K. Petersen: None.

Funding

The project described was partially supported by the National Center for Advancing Translational Sciences, Grant KL2 TR002015 to Pennsylvania State University - KL2 ESI award to Dr. Huerta-Saenz. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.